ITIH3_PONAB
ID ITIH3_PONAB Reviewed; 876 AA.
AC Q5RB37;
DT 04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT 21-DEC-2004, sequence version 1.
DT 25-MAY-2022, entry version 75.
DE RecName: Full=Inter-alpha-trypsin inhibitor heavy chain H3;
DE Short=ITI heavy chain H3;
DE Short=ITI-HC3;
DE Short=Inter-alpha-inhibitor heavy chain 3;
DE Flags: Precursor;
GN Name=ITIH3;
OS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Pongo.
OX NCBI_TaxID=9601;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Liver;
RG The German cDNA consortium;
RL Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: May act as a carrier of hyaluronan in serum or as a binding
CC protein between hyaluronan and other matrix protein, including those on
CC cell surfaces in tissues to regulate the localization, synthesis and
CC degradation of hyaluronan which are essential to cells undergoing
CC biological processes. {ECO:0000250}.
CC -!- SUBUNIT: I-alpha-I plasma protease inhibitors are assembled from one or
CC two heavy chains (HC) and one light chain, bikunin. Pre-alpha-inhibitor
CC (P-alpha-I) is composed of ITIH3/HC3 and bikunin.
CC {ECO:0000250|UniProtKB:Q06033}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC -!- PTM: Heavy chains are linked to bikunin via chondroitin 4-sulfate
CC esterified to the alpha-carboxyl of the C-terminal aspartate after
CC propeptide cleavage. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the ITIH family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CR858818; CAH91023.1; -; mRNA.
DR RefSeq; NP_001125590.1; NM_001132118.1.
DR AlphaFoldDB; Q5RB37; -.
DR SMR; Q5RB37; -.
DR STRING; 9601.ENSPPYP00000015436; -.
DR GeneID; 100172506; -.
DR KEGG; pon:100172506; -.
DR CTD; 3699; -.
DR eggNOG; ENOG502QPS2; Eukaryota.
DR InParanoid; Q5RB37; -.
DR Proteomes; UP000001595; Unplaced.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR GO; GO:0030212; P:hyaluronan metabolic process; IEA:InterPro.
DR Gene3D; 3.40.50.410; -; 1.
DR InterPro; IPR010600; ITI_HC_C.
DR InterPro; IPR013694; VIT.
DR InterPro; IPR002035; VWF_A.
DR InterPro; IPR036465; vWFA_dom_sf.
DR Pfam; PF06668; ITI_HC_C; 1.
DR Pfam; PF08487; VIT; 1.
DR Pfam; PF00092; VWA; 1.
DR SMART; SM00609; VIT; 1.
DR SMART; SM00327; VWA; 1.
DR SUPFAM; SSF53300; SSF53300; 1.
DR PROSITE; PS51468; VIT; 1.
DR PROSITE; PS50234; VWFA; 1.
PE 2: Evidence at transcript level;
KW Glycoprotein; Protease inhibitor; Proteoglycan; Reference proteome;
KW Secreted; Serine protease inhibitor; Signal.
FT SIGNAL 1..18
FT /evidence="ECO:0000255"
FT PROPEP 19..31
FT /evidence="ECO:0000250"
FT /id="PRO_0000312439"
FT CHAIN 32..637
FT /note="Inter-alpha-trypsin inhibitor heavy chain H3"
FT /id="PRO_0000312440"
FT PROPEP 638..876
FT /evidence="ECO:0000250"
FT /id="PRO_0000312441"
FT DOMAIN 26..155
FT /note="VIT"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00801"
FT DOMAIN 281..464
FT /note="VWFA"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT MOD_RES 637
FT /note="Aspartate 1-(chondroitin 4-sulfate)-ester"
FT /evidence="ECO:0000250"
FT CARBOHYD 88
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 577
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
SQ SEQUENCE 876 AA; 98410 MW; 9DADE7C3F8E24EBA CRC64;
MVALSHLGSA LQLGSLWGFP RSPFRLLGKR SLPEGVANGI EVYSTKINSK VTSRFAHNVV
TTRVVNHADT AKEVSFDVEL PKTAFITNFT LTIDGVIYPG NVKEKEVAKK QYEKAVSQGK
TAGLVKASGR KLEKFTVSVN VAAGSKVTFE LTYEELLKRH KGKYEMYLKV QPKQLVKHFE
IEVDIFEPQG ISMLDAEASF ITNDLLGSAL TKSFSGKKGH VSFKPSLDQQ RPCPTCTDSL
LNGDFTITYD VNRESPGNVQ IVNGYFVHFF APQGLPVVPK NVAFVIDISG SMAGRKLEQT
KEALLRILED MKKEDYLNFI LFSGDVSTWK EHLVQATPEN LQEARTFVKS MEDKGMTNIN
DGLLRGISML NKAREEHRVP ERSTSIVIML TDGDANVGES RPEKIQENVR NAIGGKFPLY
NLGFGNNLNY NFLENMALEN HGFARRIYED SDADLQLQGF YEEVANPLLT GVEVEYPENA
ILDLTQNTYQ HFYDGSEIVV AGRLVDEDMN SFKADVKGHG ATNDLTFTEE VDMKEMEKAL
QERDYIFGNY IERLWAYLTI EQLLEKRKNA HGEEKENLTA RALDLSLKYH FVTPLTSMVV
TKPEDNEDER AIADKPGEDA EASYQPPQNP YYYVDGDPHF IIQVPEKDDA LCFNIDEAPG
TVLRLIQDPV TGLTVNGQII GDKRGSPDSK TKKTYFGKLG IANAQMDFQV EVTTEKVTLW
NRAVQSTFSW LDTVTVMQDG LSMMINRKNM VVSFGDGVTF VVVLHQVWKK HPVHRDFLGF
YVVDSHRMSA QTHGLLGQFF QPFDFKVSDI RPGSDPTKPD ATLLVKNHQL IVTRGSQKDY
RKDASIGTKV VRWFVYNNGE GLIDGVHTDY IVPNLF